Terms: = Breast cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Staging
15 results:
1. Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial.
Žatecký J; Coufal O; Zapletal O; Kubala O; Kepičová M; Faridová A; Rauš K; Gatěk J; Kosáč P; Peteja M
World J Surg Oncol; 2023 Aug; 21(1):252. PubMed ID: 37596658
[TBL] [Abstract] [Full Text] [Related]
2. Incidence of Occult breast cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?
Wong SM; Ferroum A; Apostolova C; Alhassan B; Prakash I; Basik M; Boileau JF; Meterissian S; Aleynikova O; Wong N; Foulkes WD
Ann Surg Oncol; 2022 Oct; 29(11):6660-6668. PubMed ID: 35616744
[TBL] [Abstract] [Full Text] [Related]
3. Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy.
Dong J; Sun Q; Pan Y; Lu N; Han X; Zhou Q
BMC Cancer; 2021 Jun; 21(1):700. PubMed ID: 34126950
[TBL] [Abstract] [Full Text] [Related]
4. Negative Lymph Node Count and Lymph Node Ratio Are Associated With Survival in Male breast cancer.
Abd-Elhay FA; Elhusseiny KM; Kamel MG; Low SK; Sang TK; Mehyar GM; Nhat Minh LH; Hashan MR; Huy NT
Clin Breast Cancer; 2018 Dec; 18(6):e1293-e1310. PubMed ID: 30093263
[TBL] [Abstract] [Full Text] [Related]
5. Expression analysis of E-cad and vascular endothelial growth factor in triple-negative breast cancer patients of different ethnic groups in western China.
Jiang W; Li Y; Ou J; Wang X; Zhang C; Yi L; Xue L; Zhang M
Medicine (Baltimore); 2017 Oct; 96(42):e8155. PubMed ID: 29049198
[TBL] [Abstract] [Full Text] [Related]
6. Gene Expression Signatures in Circulating Tumor Cells Correlate with Response to Therapy in Metastatic breast cancer.
Bredemeier M; Edimiris P; Mach P; Kubista M; Sjöback R; Rohlova E; Kolostova K; Hauch S; Aktas B; Tewes M; Kimmig R; Kasimir-Bauer S
Clin Chem; 2017 Oct; 63(10):1585-1593. PubMed ID: 28778937
[TBL] [Abstract] [Full Text] [Related]
7. Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory breast cancer Cells.
Cohen EN; Gao H; Anfossi S; Mego M; Reddy NG; Debeb B; Giordano A; Tin S; Wu Q; Garza RJ; Cristofanilli M; Mani SA; Croix DA; Ueno NT; Woodward WA; Luthra R; Krishnamurthy S; Reuben JM
PLoS One; 2015; 10(7):e0132710. PubMed ID: 26207636
[TBL] [Abstract] [Full Text] [Related]
8. miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer.
Fernandez S; Risolino M; Mandia N; Talotta F; Soini Y; Incoronato M; Condorelli G; Banfi S; Verde P
Oncogene; 2015 Jun; 34(25):3240-50. PubMed ID: 25151966
[TBL] [Abstract] [Full Text] [Related]
9. Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study.
Aleskandarany MA; Negm OH; Green AR; Ahmed MA; Nolan CC; Tighe PJ; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2014 Jun; 145(2):339-48. PubMed ID: 24771047
[TBL] [Abstract] [Full Text] [Related]
10. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?
Schipper RJ; van Roozendaal LM; de Vries B; Pijnappel RM; Beets-Tan RG; Lobbes MB; Smidt ML
Breast; 2013 Dec; 22(6):1108-13. PubMed ID: 24095611
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis.
Liu Y; Zhao J; Zhang PY; Zhang Y; Sun SY; Yu SY; Xi QS
Med Sci Monit; 2012 Aug; 18(8):BR299-308. PubMed ID: 22847191
[TBL] [Abstract] [Full Text] [Related]
12. Minimal disease in the sentinel lymph node: how to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease.
Kumar S; Bramlage M; Jacks LM; Goldberg JI; Patil SM; Giri DD; Van Zee KJ
Ann Surg Oncol; 2010 Nov; 17(11):2909-19. PubMed ID: 20532987
[TBL] [Abstract] [Full Text] [Related]
13. [Are bone scintigraphy examinations requested in oncologic patients according to established indications?].
Cortés Romera M; Talavera Rubio MP; García Vicente AM; Ruiz Solís S; Poblete García VM; Rodríguez Alfonso B; Palomar Muñoz A; Soriano Castrejón A
Rev Esp Med Nucl; 2007; 26(5):286-93. PubMed ID: 17910837
[TBL] [Abstract] [Full Text] [Related]
14. Factors predicting failure to identify a sentinel lymph node in breast cancer.
Chagpar AB; Martin RC; Scoggins CR; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; Noyes RD; Ley PB; Tuttle TM; McMasters KM
Surgery; 2005 Jul; 138(1):56-63. PubMed ID: 16003317
[TBL] [Abstract] [Full Text] [Related]
15. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
[TBL] [Abstract] [Full Text] [Related]
